Anthony D. Yang

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ryan J. Ellis · 3 shared papers, 2020–2026 · strength 0.70
   • Paper Assessing the interplay of operative volume at the hospital and surgeon level for pancreatic cancer. DOI 10.1016/j.hpb.2026.07.007↗
   • Paper Use of large language models as clinical decision support tools for management pancreatic adenocarcinoma using National… DOI 10.1016/j.surg.2025.109267↗
   • Paper National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resec… DOI 10.1245/s10434-019-08023-1↗
2. Dhruv J. Patel · 1 shared paper, 2026 · strength 0.32
   • Paper Assessing the interplay of operative volume at the hospital and surgeon level for pancreatic cancer. DOI 10.1016/j.hpb.2026.07.007↗
3. Christian Max Schmidt · 1 shared paper, 2026 · strength 0.32
   • Paper Assessing the interplay of operative volume at the hospital and surgeon level for pancreatic cancer. DOI 10.1016/j.hpb.2026.07.007↗
4. Alexa J. Hughes · 1 shared paper, 2025 · strength 0.26
   • Paper Use of large language models as clinical decision support tools for management pancreatic adenocarcinoma using National… DOI 10.1016/j.surg.2025.109267↗
5. Kristen N. Kaiser · 1 shared paper, 2025 · strength 0.26
   • Paper Use of large language models as clinical decision support tools for management pancreatic adenocarcinoma using National… DOI 10.1016/j.surg.2025.109267↗
6. Ryan P. Merkow · 1 shared paper, 2020 · strength 0.13
   • Paper National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resec… DOI 10.1245/s10434-019-08023-1↗
7. David J. Bentrem · 1 shared paper, 2020 · strength 0.13
   • Paper National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resec… DOI 10.1245/s10434-019-08023-1↗
8. Matthew H. G. Katz · 1 shared paper, 2015 · strength 0.04
   • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
9. Huamin Wang · 1 shared paper, 2015 · strength 0.04
   • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
10. Deyali Chatterjee · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
11. Robert A. Wolff · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
12. Christina Lynn Roland · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
13. Jean‐Nicolas Vauthey · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
14. Jason B. Fleming · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
15. Gauri Rajani Varadhachary · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
16. Christopher H. Crane · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
17. Peter W. T. Pisters · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
18. Jeffrey E. Lee · 1 shared paper, 2015 · strength 0.04
    • Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.